Adimab scientists report the isolation of highly potent anti-Ebola virus antibodies from recent Zaire outbreak
3 institutional releases
Published in Science · View the paper (DOI)
Researchers at Adimab isolated a broad panel of neutralizing anti-Ebola virus antibodies from a survivor of the 2014 outbreak. The study highlights the speed and effectiveness of Adimab's single B cell isolation platform, which was able to identify over 300 monoclonal antibodies within weeks of receiving a blood sample.
Coverage from 3 institutions
- Adimab scientists report the isolation of highly potent anti-Ebola virus antibodies from recent Zaire outbreak MacDougall Biomedical Communications, Inc. · Feb 18, 2016 · first to report
- Antibodies from an Ebola survivor reveal a potential new vaccine target American Association for the Advancement of Science (AAAS) · Feb 18, 2016
- Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor Scripps Research Institute · Feb 19, 2016